2021-001087-24
A Randomized, Parallel-Group, Single-Attack, Open-Label Study to Evaluate the Efficacy of Almotriptan and Ubrogepant for the Acute Treatment of Migraine (ATOM).
Danish Headache Center·EU Clinical Trials Register
Study focus
- Disease/Condition
- Migraine
Sponsor & location
- Primary sponsor
- Danish Headache Center
Timeline & enrollment
- Phase
- N/A
- Start date
- N/A
- End date
- N/A
ICD-10 classifications
MigraineOther migraineMigraine, unspecifiedComplicated migraineHeadache
Data source
- Registry
- EU Clinical Trials Register
- Trial ID
- 2021-001087-24
- Type
- Non-Device Trial
About this record
Access comprehensive clinical trial information for 2021-001087-24 through Pure Global AI's free database. This phase not specified trial is sponsored by Danish Headache Center and is currently status unknown. The study focuses on Migraine.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to EU Clinical Trials Register data, helping medical device and pharmaceutical companies navigate clinical research efficiently.